| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 766896 | 08462001IP3 | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 375 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462001IP3/08462001IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462001IP3/08462001IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2025-02-05 | 1 | 1 | 1 | 2025-02-06 | 2025-02-05 | 1 | 2026-03-11 | View Edit Delete | ||||||||||||
| 766897 | 90128 | MICAFUNGINA MACLEODS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | MICAFUNGINA MACLEODS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90128/90128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90128/90128_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 67266 | MACLEODS PHARMA ESPANA S.L.U. | 2025-02-05 | 1 | 1 | 1 | 2025-02-06 | 2025-02-05 | 1 | 2025-11-19 | View Edit Delete | ||||||||||||
| 766898 | 90127 | MICAFUNGINA MACLEODS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | MICAFUNGINA MACLEODS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90127/90127_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90127/90127_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 67266 | MACLEODS PHARMA ESPANA S.L.U. | 2025-02-05 | 1 | 1 | 1 | 2025-02-06 | 2025-02-05 | 1 | 2025-11-19 | View Edit Delete | ||||||||||||
| 766904 | 89357 | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 25 comprimidos | 25 mg | 5 | 25 | 10 | 25 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89357/89357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89357/89357_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2025-02-04 | 1 | 2026-03-26 | View Edit Delete | ||||||||||||
| 766905 | 89357 | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | HIDROXIZINA TARBIS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 50 comprimidos | 25 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89357/89357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89357/89357_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2025-02-04 | 1 | 2026-03-26 | View Edit Delete | ||||||||||||
| 766868 | 90115 | CANDESARTAN STADAFARMA 16 MG COMPRIMIDOS EFG | CANDESARTAN STADAFARMA 16 MG COMPRIMIDOS EFG, 28 comprimidos | 16 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90115/90115_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90115/90115_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2025-02-03 | 1 | 1 | 1 | 2025-02-04 | 2025-02-03 | 1 | 2026-01-05 | View Edit Delete | ||||||||||||
| 766869 | 90116 | CANDESARTAN STADAFARMA 32 MG COMPRIMIDOS EFG | CANDESARTAN STADAFARMA 32 MG COMPRIMIDOS EFG, 28 comprimidos | 32 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90116/90116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90116/90116_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2025-02-03 | 1 | 1 | 1 | 2025-02-04 | 2025-02-03 | 1 | 2026-01-05 | View Edit Delete | ||||||||||||
| 766870 | 90117 | CANDESARTAN STADAFARMA 4 MG COMPRIMIDOS EFG | CANDESARTAN STADAFARMA 4 MG COMPRIMIDOS EFG, 14 comprimidos | 4 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90117/90117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90117/90117_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2025-02-03 | 1 | 1 | 1 | 2025-02-04 | 2025-02-03 | 1 | 2025-10-10 | View Edit Delete | ||||||||||||
| 766871 | 90118 | CANDESARTAN STADAFARMA 8 MG COMPRIMIDOS EFG | CANDESARTAN STADAFARMA 8 MG COMPRIMIDOS EFG, 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90118/90118_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90118/90118_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2025-02-03 | 1 | 1 | 1 | 2025-02-04 | 2025-02-03 | 1 | 2026-01-05 | View Edit Delete | ||||||||||||
| 766867 | 90114 | IBUPROFENO COMBIX 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IBUPROFENO COMBIX 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 400 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90114/90114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90114/90114_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2025-02-03 | 1 | 1 | 1 | 2025-02-04 | 2025-02-03 | 1 | 2025-09-02 | View Edit Delete | ||||||||||||
| 718771 | 82365 | AZITROMICINA TEVAGEN 250 MG COMPRIMIDOS DISPERSABLES | AZITROMICINA TEVAGEN 250 MG COMPRIMIDOS DISPERSABLES, 6 comprimidos | 250 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82365/82365_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82365/82365_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2017-08-30 | 1 | 1 | 1 | 2025-01-31 | 2025-01-31 | 1 | 2025-02-08 | View Edit Delete | ||||||||||||
| 718772 | 82366 | AZITROMICINA TEVAGEN 500 MG COMPRIMIDOS DISPERSABLES EFG | AZITROMICINA TEVAGEN 500 MG COMPRIMIDOS DISPERSABLES EFG, 3 comprimidos | 500 mg | 5 | 3 | 10 | 3 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82366/82366_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82366/82366_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2017-08-30 | 1 | 1 | 1 | 2025-01-31 | 2025-01-31 | 1 | 2025-02-08 | View Edit Delete | ||||||||||||
| 766806 | 88191 | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG | ESPIRONOLACTONA ORION 100 MG COMPRIMIDOS EFG, 30 comprimidos (PVC/Al) | 100 mg | 5 | 30 | 10 | 30 comprimidos (PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88191/88191_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88191/88191_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42344 | ORION PHARMA S.L. | 2023-03-31 | 1 | 1 | 1 | 2023-03-31 | 2025-01-31 | 1 | 2026-05-11 | View Edit Delete | ||||||||||||
| 766805 | 837871425042018IP | FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 2,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7264 | ABACUS MEDICINE A/S | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-02-03 | View Edit Delete | ||||||||||||
| 766799 | 034972291IP | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 20 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972291IP/034972291IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | EUROMED PHARMA SPAIN S.L. | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-09 | View Edit Delete | ||||||||||||
| 766800 | 034972442IP | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES | NEXIUM MUPS 40 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/034972442IP/034972442IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28616 | EUROMED PHARMA SPAIN S.L. | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-09 | View Edit Delete | ||||||||||||
| 766801 | 90107 | TICAGRELOR OLPHA 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TICAGRELOR OLPHA 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos (PVC/PVDC/Al) | 90 mg | 5 | 56 | 10 | 56 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90107/90107_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90107/90107_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67225 | OLPHA AS | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 766803 | 90108 | TICAGRELOR OLPHA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TICAGRELOR OLPHA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (PVC/PVDC/Al) | 60 mg | 5 | 60 | 10 | 60 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90108/90108_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90108/90108_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67225 | OLPHA AS | 2025-01-31 | 1 | 1 | 1 | 2025-02-01 | 2025-01-31 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 766762 | 1241886001 | LAZCLUZE 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LAZCLUZE 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 80 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241886001/1241886001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241886001/1241886001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2025-01-29 | 1 | 1 | 1 | 2025-01-30 | 2025-01-29 | 1 | 2025-11-12 | View Edit Delete | ||||||||||||
| 766763 | 1241886005 | LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LAZCLUZE 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 240 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241886005/1241886005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241886005/1241886005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2025-01-29 | 1 | 1 | 1 | 2025-01-30 | 2025-01-29 | 1 | 2025-11-12 | View Edit Delete |
Page 43 of 1036, showing 20 records out of 20704 total, starting on record 841, ending on 860